A novel highly oxygenated norsesquiterpene, pogonatherumol (1), with two known flavone C-glycosides (2-3), was isolated from Pogonatherum crinitum. e structure of the new compound was illuminated based on its spectroscopic data and X-ray analysis. Compounds 1 and 3 inhibited NO production in the mouse peritoneal macrophage (64.5 ± 7.2% and 61.6 ± 5.8%, respectively, at a concentration of 50 μM). e three compounds were inactive when tested against two human cancer cell lines (IC 50 values > 50 μM).
Introduction
Pogonatherum crinitum, is one of the species in the genus Pogonatherum of Gramineae family, which has been used as a natural medicine in Chinese folk [1] , for treatment of diabetes, urinary tract infection, jaundice hepatitis, and nephritis [2] [3] [4] [5] . Previous phytochemical studies on this plant have led to a series of flavones and lignins, some of which showed anti-inflammatory and antifungal activities [6, 7] . In order to discover structurally and biologically interesting compounds from P. crinitum, a novel highly oxygenated norsesquiterpene, pogonatherumol (1) with two known flavone C-glycosides was investigated (Figure 1) . Herein, the isolation and structural characterization of the compounds and their biological activities are reported in this paper.
Experimental

General Experimental
Procedures. X-ray dif-segment intensity data of 1 were collected on an MAC DIP-2030K diffractometer with graphite-monochromated Mo Kα radiation and were corrected by Lorentz and polarization. An XT-5B micromelting point apparatus was used to determine the melting point. JEOL ECZ-400S, JASCO V-650, and Nicolet iS5N spectrophotometers manufactured by ermo Scientific were used to record NMR, UV, and IR spectra, respectively.
ermo Scientific LTQ Orbitrap XL was used to collect HRESIMS spectra. Column chromatography (CC) was performed with silica gel (300-400 mesh), polyamide (60-100 mesh), Sephadex LH-20, D101 macroporous, and ODS (50 μm). Preparative HPLC made up for an LC-20AP instrument, an SPD-20A detector, and an ODS-A column (YMC, 250 × 20 mm, 5 μm) was used to purify the compounds. e crystallographic data of the structure of pogonatherumol (deposition number: CCDC 1842928) were deposited at the Cambridge Crystallographic Data Centre.
Extraction and
Biological Activities.
Two cell lines, human ovarian neoplasm cell (A2780) and human colon cancer cell line (HCT-116), were used to test the tumor cytotoxic activities, and Taxol was used as a positive control. e method was according to the previously described [8] . LPS-induced RAW264.7 macrophage was used to evaluate the NO production inhibition activity of the three compounds. Dexamethasone was used as a positive control, and the test method was according to the literature [9, 10] .
Results and Discussion
Pogonatherumol (1) was obtained as colorless needles (MeOH).
e IR spectrum of 1 showed 3313, 1672, and 1566 cm −1 absorption bands, which were assigned to hydroxyl, carbonyl, and olefin functionalities, respectively. e molecular formula was determined to be C 14 (2H, s, H-3) ), an aromatic proton δ H 6.76 (1H, s, H-6), an olefin proton δ H 6.56 (1H, m, H-10), and two hydroxyls (10.06 (1H, s) and 8.74 (1H, s) ). And the 13 C NMR (Table 1) and DEPT spectra showed fourteen carbons, including a carbonyl, a methene, three methines, three methyls, and six aromatic carbons, two of them bearing oxygen atoms (C-4 and C-5). HMBC correlations of H-6/C-4, C-5, and C-8; H-3/C-1, C-2, C-8, and C-9; 4-OH/C-5 and C-9; and 5-OH/C-4, C-5, and C-6 confirmed the presence of the indanone skeleton (Figure 2 ). An isopropyl (δ H 1.12, 1.12 (3H each, both d, J � 6.8 Hz, H 3 -13, 14) and 4.06 (1H, m, H-12) ) was attached to C-7, which could be confirmed by the HMBC correlation from H-13 and H-14 to C-12 and C-7 and from H-12 to C-6, C-7, and C-8. Further HMBC correlations of H-11/C-10 and C-2 and of H-10/C-1 indicated that an ethylidene was fixed in C-2, and NOESY correlation from H 3 -11 to H-3 suggested the trans-configuration of double bonds between C-2 and C-10 ( Figure 2) . Finally, the proposed structure of 1, (E)-2-ethylidene-4,5-dihydroxy-7-isopropyl-2,3-dihydro-1H-inden-1-one, named "pogonatherumol" was confirmed by an X-ray crystallography analysis. e ORTEP drawing, with the atomnumber scheme indicated, is shown in Figure 3 . * New compound. 
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In addition to pogonatherumol, two known C-glycosides, schaftoside (2) [11] and isoschaftoside (3) [12] , were identified by comparing their ESIMS and 1 H and 13 C NMR data with those reported in the literature.
Pogonatherumol (1) with a fused indanone skeleton has not been previously reported as a natural product. Notably, it seems to be a novel rearrangement of norsesquiterpene.
Meanwhile, the inhibited NO production and the tumor cytotoxic activities of three compounds were evaluated. Compounds 1 and 3 inhibited NO production in the mouse peritoneal macrophage (64.5 ± 7.2% and 61.6 ± 5.8%, respectively, at a concentration of 50 μM), while the positive control dexamethasone gave an inhibitory ratio of 59.4.1 ± 6.2% at a concentration of 10 μM. All compounds were also evaluated in vitro for cytotoxicity against A2780 and HCT-116 cell lines employing an MTT assay with Taxol as the positive control. e three compounds were inactive when tested against the two human tumor cell lines (IC 50 values ≥ 50 μM).
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